Gillet; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gillet; Daniel.The latest application filed is for "new dihydroquinazolinones exhibiting protective activity against intracellular-acting toxins, intracellular viruses and bacteria".

Company Profile

1.9.13

Gillet; Daniel - Antony FR
Gillet; Daniel - Paris FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New Dihydroquinazolinones Exhibiting Protective Activity Against Intracellular-acting Toxins, Intracellular Viruses And Bacteria App 20220002289 - Cintrat; Jean-Christophe ; et al.	2022-01-06
Benzodiazepine derivatives for use in the treatment of Chlamydiales infections Grant 11,136,299 - Gillet , et al. October 5, 2	2021-10-05
Adamantane or Bicyclic Monoterpenoid Derivatives for Use in the Treatment of Leishmaniasis App 20200281873 - Gillet; Daniel ; et al.	2020-09-10
Adamantane or pinene derivatives for use in the treatment of chlamydiales infections Grant 10,039,727 - Gillet , et al. August 7, 2	2018-08-07
HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with the activation of the HB-EGF/EGFR pathway Grant 9,758,552 - Gillet , et al. September 12, 2	2017-09-12
Compounds Which Have a Protective Activity with Respect to the Action of Toxins and of Viruses with an Intracellular Mode of Action App 20170233386 - Lopez; Roman ; et al.	2017-08-17
2,3-dihydroquinazolin-4(1H)-one derivatives for use in the treatment of viral infections Grant 9,675,615 - Gillet , et al. June 13, 2	2017-06-13
Quinazolinone derivatives for use in the treatment of chlamydiales infections Grant 9,598,406 - Gillet , et al. March 21, 2	2017-03-21
Compounds having a protective activity against toxins with intracellular activity Grant 9,540,356 - Gillet , et al. January 10, 2	2017-01-10
Benzodiazepine Derivatives for Use in the Treatment of Chlamydiales Infections App 20160311783 - Gillet; Daniel ; et al.	2016-10-27
Quinazolinone Derivatives for Use in the Treatment of Chlamydiales Infections App 20160311815 - Gillet; Daniel ; et al.	2016-10-27
Adamantane or Pinene Derivatives for Use in the Treatment of Chlamydiales Infections App 20160310448 - Gillet; Daniel ; et al.	2016-10-27
Compounds Which Have A Protective Activity With Respect To The Action Of Toxins And Of Viruses With An Intracellular Mode Of Action App 20160083355 - Lopez; Roman ; et al.	2016-03-24
New Compounds Having A Protective Activity Against Toxins With Intracellular Activity App 20150291568 - Gillet; Daniel ; et al.	2015-10-15
2,3-dihydroquinazolin-4(1h)-one Derivatives For Use In The Treatment Of Viral Infections App 20150250788 - Gillet; Daniel ; et al.	2015-09-10
Inhibitors of the shiga toxins trafficking through the retrograde pathway Grant 9,034,868 - Gillet , et al. May 19, 2	2015-05-19
Hb-egf Inhibitor Derived From The R Domain Of Diphtheria Toxin For The Treatment Of Diseases Associated With The Activation Of The Hb-egf/egfr Pathway App 20150051146 - Gillet; Daniel ; et al.	2015-02-19
Inhibitors Of The Shiga Toxins Trafficking Through The Retrograde Pathway App 20140073633 - GILLET; Daniel ; et al.	2014-03-13
Inhibitors of the Shiga toxins trafficking through the retrograde pathway Grant 8,609,732 - Gillet , et al. December 17, 2	2013-12-17
Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action App 20120283249 - Lopez; Roman ; et al.	2012-11-08
Inhibitors Of The Shiga Toxins Trafficking Through The Retrograde Pathway App 20110201601 - Gillet; Daniel ; et al.	2011-08-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.